Question 1: Purpose of therapy

Indicate purpose of therapy:

  • Induction (frontline)
  • Consolidation/intensification after achieving first CR/Cri
  • Maintenance/ continuation after achieving first CR/Cri
  • Reinduction after fist disease relapse or later relapse
  • Consolidation/intensification after disease relapse, after achieving second or later CR/CRi
  • Maintenance/continuation after disease relapse, after achieving second or later CR/Cri
  • Other (Go to question 2. If not, proceed to question 3.)

Question 2: Specify Other

Specify other purpose of therapy.

Question 3-4: Date line of therapy started

Indicate known or unknown. If known, report the date (YYYY-MM-DD) when therapy was started in Question 4.

Question 5-6: Date line of therapy stopped

Indicate known or unknown. If known, report the date (YYYY-MM-DD) when therapy was stopped in Question 5.

Question 7: Was Mylotarg™ given with combination chemotherapy as part of this line of therapy?

Indicate yes or no. If yes, move to Question 8. If no, move to question 10.

Question 8: Specify systemic therapy.

Check all therapies that apply to this line of therapy. If other, check “other systemic therapy” and move to question 9.

Question 9: Specify other therapy.

Indicate therapy that was used in combination with Mylotarg™ that was not listed.

Question 10: Height used for Mylotarg™ dose.

Indicate height used for dosage and check unit of measurement (inches or centimeters).

Question 11: Body weight used for Mylotarg™ use.

Indicate weight used for dosage and check unit of measurement (pounds or kilograms).

Questions 12: Specify the number of instances Mylotarg™ was administered as a part of this line of therapy.

Indicate the number of instances Mylotarg™ was used. CIBMTR also recommends to attach the medication administration record.

Questions 13-32: Instance.

Specify date dose administered (YYYY-MM-DD) for each instance. Specify dose administered (mg/mg 2) for each instance.

Question 33: Total Mylotarg™ dose given as part of this line of therapy

Indicate known or unknown. If known, go to question 34. If unknown, skip to question 35.

Question 34: Mylotarg™ dose

Indicate Mylotarg™ dose given as part of this line of therapy in mg/m 2.

Question 35: Best response to line of therapy

Indicate best response to line of therapy:

  • Complete remission (CR): ALL of the following criteria without progression for at least four weeks: <5% blasts in the bone marrow, no blasts with Auer rods, no extramedullary disease, ANC of > 1,000/uL, platelets >1000,000/uL
  • Complete remission with incomplete hematologic recovery (Cri): All CR criteria except for neutropenia (<1,000/uL) and/or thrombocytopenia (<100,000/uL)
  • No complete remission

Question 36: Date Assessed

Indicate date of assessment (YYYY-MM-DD).

Repeat questions 1-36 for each line of therapy and submit the form.

Last modified: Jul 26, 2020

Need more help with this?
Don’t hesitate to contact us here.

Was this helpful?

Yes No
You indicated this topic was not helpful to you ...
Could you please leave a comment telling us why? Thank you!
Thanks for your feedback.